Company: CERO
Filing Date: 2025-08-22
Form Type: 10-Q
Source: 0001213900-25-079898
Chunk: 43

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 10-Q
Item: Item 1
Chunk 43
---
5. Such stockholder approval was obtained on May
29, 2025. If, on or after the Series D Stockholder Approval Date, the Company issues any shares of Common Stock for a consideration
per share (the “New Issuance Price”) less than a price equal to the Series D Conversion Price in effect immediately
prior to such issuance, the Conversion Price shall be reduced to the Series D New Issuance Price.

If 30 days
or 60 days following the occurrence of the later of (x) the Series D Stockholder Approval Date and (y) the earlier
of (a) the effective date of the registration statement to be filed pursuant to the Registration Rights Agreement and (b) the
date that the Series D Preferred Stock is eligible to be resold without restriction under Rule 144 of the Securities Act, the
Series D Conversion Price then in effect is the greater of $3.12 and the Market Price (as defined in the Series D Certificate
of Designations) then in effect (the “Series D Adjustment Price”), the Conversion Price shall automatically lower to
the Series D Adjustment Price.

On August 13, 2025, the Company
and the Investors of Series D Preferred Stock entered into an Amendment and Limited Waiver Agreement (the “Waiver Agreement”),
whereby the Investors (i) amended the Registration Rights Agreement to extend certain deadlines therein and (ii) waive certain provisions
of the Series D COD. Pursuant to the Waiver Agreement, the Company and the Series D Preferred Holders acknowledged that it was inefficient
and impracticable to file the Registration Statement prior to the consummation of additional closings. Accordingly, the filing deadline
with respect to the initial Registration Statement was extended to August 15, 2025; The Registration Statement on Form S-3 was filed on
August 11, 2025. Additionally, the “Effectiveness Deadline” with respect to the initial Registration Statement required to
be filed, shall be the earlier of the (A) October 15, 2025 (or, if such Registration Statement is subject to a full review by the SEC,
November 30, 2025 and (B) fifth Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the
SEC that such Registration Statement will not be reviewed or will not be subject to further review and (ii) with